Ruan Y, Si W, Zhang L
FuWai Cardiovascular Hospital, Chinese Academy of Medical Sciences, Beijing.
Zhonghua Bing Li Xue Za Zhi. 1996 Apr;25(2):89-92.
With the purpose of studying the relationship between the pathological gradings and changes of the hemodynamics as well as the collagen typing of the pulmonary arteries in pulmonary hypertension, 9 autopsy cases including 6 cases of unexplained plexogenic pulmonary arteriopathy, 2 cases of diffuse interstitial fibrosis of lung and 1 case of chronic embolic pulmonary hypertension were collected as the pulmonary hypertension group (PAH). The pathological lesions of PAH in pulmonary arteries were graded as follows: Grade I showed medial hypertrophy; Grade II medial hypertropy and intimal cellular proliferation: Grade III medial hypertrophy and intimal fibrosis or embolic occlusion: Grade IV the above lesions plus plexiform lesions with/without focal necrotizing arteritis. Immunohistochemical staining with antibodies against collagen type I and type IV was performed in the paraffin sections of lungs using PAP method. The result indicated that: 1) there were significant differences between the mean medial thickness in pulmonary arteries (6.1% in the normal lung group and 26.1% in PAH) and the density of pulmonary artery (22.6% arterioles/cm2 in the normal group and 44.6 arterioles/cm2 in PAH) respectively (P < 0.01). 2) there was positive correlation between the grades of PAH lesions and the mean pulmonary arterial pressure (r = 0.68 P < 0.01). 3) collagen type I fibriles increased in the old lesions and collagen type IV fibrils were dominant in the early stage of PAH (reversible lesion).
为研究肺动脉高压时病理分级与血流动力学变化以及肺动脉胶原类型之间的关系,收集了9例尸检病例作为肺动脉高压组(PAH),其中包括6例不明原因的丛状肺血管病、2例肺弥漫性间质纤维化和1例慢性栓塞性肺动脉高压。PAH的肺动脉病理损害分级如下:I级表现为中膜肥厚;II级为中膜肥厚和内膜细胞增生;III级为中膜肥厚和内膜纤维化或栓塞性阻塞;IV级为上述病变加丛状病变伴/不伴局灶性坏死性动脉炎。采用PAP法对肺石蜡切片进行抗I型和IV型胶原抗体的免疫组织化学染色。结果表明:1)肺动脉平均中膜厚度(正常肺组为6.1%,PAH组为26.1%)和肺动脉密度(正常组为22.6条小动脉/平方厘米,PAH组为44.6条小动脉/平方厘米)之间分别存在显著差异(P<0.01)。2)PAH病变分级与平均肺动脉压之间呈正相关(r=0.68,P<0.01)。3)I型胶原纤维在陈旧性病变中增加,IV型胶原纤维在PAH早期(可逆性病变)占主导。